Authorisation: genetically modified oilseed rape MON 94100

Commission Implementing Decision (EU) 2023/416 of 22 February 2023 authorising the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape MON 94100 (MON-941ØØ-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2023) 1135) (Only the Dutch text is authentic) (Text with EEA relevance)

Update

The EU has authorised the placement on the EU market of food, ingredients and feed containing, consisting of, or produced from genetically modified (GM) oilseed rape MON 94100. The authorisation does not cover cultivation in the EU.

Impacted Products

oilseed rape

What is changing?

This Decision permits the sale on the EU market of food, food ingredients and feed containing, consisting of, or produced from GM oilseed rape MON 94100. Specifications regarding the use, labelling and methods of detection for this GM oilseed rape are set out in the Annex. The authorisation does not permit cultivation of this oilseed rape in the EU.

Why?

In its evaluation of the application for herbicide tolerant GM oilseed rape MON 94100, EFSA (2022) found that it is as safe as conventional oilseed rape regarding potential effects on human and animal health and the environment, and that it does not represent any nutritional concern for humans and animals.

Timeline

Date of publication: 24 February 2023.

The EU authorisation for GM oilseed rape MON 94100 will remain valid for 10 years.

Background

A list of all authorised GM products can be found on the EU Register of authorised GMOs.

The authorisation of GM crops remains an extremely sensitive political issue in the EU. In this particular case, concerns have been raised in the European Parliament that adoption of this oilseed rape could encourage the use of herbicides (European Parliament 2023).

The authorisation process requires EU Member States to authorise or reject applications. In recent years, there has generally not been enough political support (a “qualified majority” of Member States) to reach a decision to either authorise or reject applications. In such cases, as here for GM oilseed rape MON 94100, the Commission is permitted to authorise the product in the light of EFSA’s positive risk assessment.

Resources

Sources

---

---